NEW YORK (GenomeWeb) – Sequenom has filed a shelf registration to offer from time to time up to $300 million in securities. 

In a document filed with the US Securities and Exchange Commission last Friday, the firm said that it may offer securities in the form of common stock, preferred stock, debt securities, warrants, and any combination of the securities. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Customers might want to consider what they might learn about their risk of diseases like Alzheimer's before snagging the genetic testing kits that are on many gift guides this year, writes.

The Wall Street Journal reports there is uncertainty surrounding whether He Jiankui's embryo editing did what he said it did.

Stat News reports that the pause on procuring fetal tissue for intramural US National Institutes of Health research will soon affect additional labs there.

In Nature this week: genomic analysis of the invasive fall webworm, amp of constrained coding regions within the human genome, and more.